Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


J Appl Physiol (June 7, 2007). doi:10.1152/japplphysiol.00037.2007
This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
103/2/594    most recent
00037.2007v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanchez, J.
Right arrow Articles by Wagner, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanchez, J.
Right arrow Articles by Wagner, E. M.
Submitted on January 9, 2007
Accepted on May 31, 2007

The role of CXCR2 in systemic neovascularization of the mouse lung

Jesus Sanchez1, Aigul Moldobaeva1, Jessica McClintock1, John Jenkins1, and Elizabeth M. Wagner1*

1 Medicine, Johns Hopkins University, Baltimore, Maryland, United States

* To whom correspondence should be addressed. E-mail: wagnerem{at}jhmi.edu.

We previously showed increased expression of the ELR+, CXC chemokines in the lung after left pulmonary artery obstruction. These chemokines have been shown in other systems to bind their G-protein coupled receptor, CXCR2, and promote systemic endothelial cell proliferation, migration, and capillary tube formation. In the present study, we blocked CXCR2 in vivo using a neutralizing antibody and also studied mice that were homozygous null for CXCR2. To estimate the extent of neovascularization in this model, we measured systemic blood flow to the left lung 14 days after left pulmonary artery ligation (LPAL). We found blood flow significantly reduced (67% decrease) with neutralizing antibody treatment compared to controls. However, blood flow was not altered in the CXCR2 deficient mice compared to wild type controls after LPAL. To test for ligand availability, we measured MIP-2 protein in lung homogenates after LPAL, since this is the predominant CXC chemokine previously shown to be increased after LPAL (22). MIP-2 protein was 2-4 fold higher in the left lung relative to the right lung in all treatment groups 4 hrs after LPAL and this increase did not differ among groups. We speculate that the CXCR2 deficient mice have compensatory mechanisms that mitigate their lack of gene expression and conclude that CXCR2 contributes to chemokine-induced systemic angiogenesis after pulmonary artery obstruction.




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
A. Sukkar, J. Jenkins, J. Sanchez, and E. M. Wagner
Inhibition of CXCR2 attenuates bronchial angiogenesis in the ischemic rat lung
J Appl Physiol, May 1, 2008; 104(5): 1470 - 1475.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. A. Abdel-Malak, C. B. Srikant, A. S. Kristof, S. A. Magder, J. A. Di Battista, and S. N. A. Hussain
Angiopoietin-1 promotes endothelial cell proliferation and migration through AP-1-dependent autocrine production of interleukin-8
Blood, April 15, 2008; 111(8): 4145 - 4154.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. M. Wagner, J. Sanchez, J. Y. McClintock, J. Jenkins, and A. Moldobaeva
Inflammation and ischemia-induced lung angiogenesis
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L351 - L357.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1948 by the American Physiological Society.